X4 Pharmaceuticals, Inc. (XFOR): Price and Financial Metrics
XFOR Price/Volume Stats
| Current price | $4.26 | 52-week high | $33.90 |
| Prev. close | $3.70 | 52-week low | $2.67 |
| Day low | $3.83 | Volume | 246,358 |
| Day high | $4.35 | Avg. volume | 134,428 |
| 50-day MA | $4.72 | Dividend yield | N/A |
| 200-day MA | $13.33 | Market Cap | 24.66M |
XFOR Stock Price Chart Interactive Chart >
X4 Pharmaceuticals, Inc. (XFOR) Company Bio
X4 Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company specializes in developing novel therapeutics designed to improve immune cell trafficking to treat rare diseases including primary immunodeficiencies and cancer. X4's oral small molecule drug candidates antagonize the CXCR4 pathway which plays a central role in immune surveillance.
XFOR Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
XFOR Price Returns
| 1-mo | 31.48% |
| 3-mo | -59.64% |
| 6-mo | -64.42% |
| 1-year | -86.08% |
| 3-year | -87.54% |
| 5-year | -98.38% |
| YTD | -80.64% |
| 2024 | -12.51% |
| 2023 | -15.56% |
| 2022 | -56.64% |
| 2021 | -64.39% |
| 2020 | -39.91% |